Insider Shareholders with Direct Ownership of Logic Bio Therapeutics, Inc. (LOGC)
This section provides a comprehensive overview of the insiders with direct ownership of Logic Bio Therapeutics, Inc. (LOGC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LogicBio Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Kyle Chiang
Chief Operating Officer |
9,360 | 2,977 | 23,387 $0 | 2 |
Apr 16, 2021
Reduced 11.29%
|
|
Cecilia Jones
Chief Financial Officer |
5,939 | 2,175 | 3,764 $0 | 2 |
Jan 12, 2022
Reduced 36.62%
|
|
Daniel P O'Connell
Director |
2,513 | 0 | 2,513 $0 | 1 |
Dec 10, 2020
Added 50.0%
|
|
Mark J Enyedy
Director |
2,921 | 2,921 | 0 $0 | 2 |
Nov 16, 2022
Reduced 100.0%
|
|
Michael S Wyzga
Director |
3,141 | 3,141 | 0 $0 | 2 |
Nov 16, 2022
Reduced 100.0%
|
|
Leon Chen
Director |
3,298 | 22,333 | 0 $0 | 2 |
Nov 16, 2022
Reduced 100.0%
|
|
Mark A Kay
Director |
2,199 | 784,557 | 0 $0 | 2 |
Nov 16, 2022
Reduced 100.0%
|
|
Richard A Moscicki
Director |
3,916 | 3,916 | 0 $0 | 2 |
Nov 16, 2022
Reduced 100.0%
|
|
Frederic Chereau
President, CEO |
23,414 | 261,353 | 0 $0 | 3 |
Nov 16, 2022
Reduced 100.0%
|
|
Daniel Gruskin
Chief Medical Officer |
4,798 | 4,798 | 0 $0 | 3 |
Nov 16, 2022
Reduced 100.0%
|